Observational Study of the EnligHTN Renal Denervation System in Europe

CompletedOBSERVATIONAL
Enrollment

68

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Uncontrolled Hypertension
Interventions
DEVICE

EnligHTN™ Renal Denervation System

The EnligHTN™ Renal Denervation System is designed to deliver radiofrequency (RF) energy to the renal nerves to achieve targeted denervation. The system consists of the EnligHTN™ RF Ablation Generator (generator), the EnligHTN™ Renal Artery Ablation Catheter (ablation catheter), and the EnligHTN™ Guiding Catheter (optional).

Trial Locations (13)

6042

Hôpital Civil Marie Curie, Lodelinsart

13419

North Estonia Medical Centre, Tallinn

20131

Instituto Clinico Citta Studi, Milan

21005

Hospital Juan Ramon Jimenez, Huelva

24040

Policlinico San Marco, Osio Sotto

24068

Dr. Gianluigi Patelli, Alzano Lombardo

28100

Clinica San Gaudenzio, Novara

31008

Clinica Universitaria de Navarra, Pamplona

36204

Hospital Xeral-Cies de Vigo, Vigo

46206

Hospital Universitari i Politecnic La Fe, Valencia

2795-523

Hospital de Santa Cruz, Carnaxide

06010

Hopspital Infanta Cristina, Badajoz

BT63 5QQ

Craigavon Area Hospital, Portadown

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY